Numinus Completes First Extraction of its Psilocybe Mushrooms Dec 17 • 5 min read Numinus Wellness Inc. has completed the first legal extraction of Psilocybe mushrooms in Canada by a public company for research and development purposes.
Ehave, Inc. Announces KetaDASH for Ketamine Home Delivery and Purchase of Curedash Assets Dec 16 • 4 min read Ehave, Inc. announced KetaDASH, an Intravenous (IV) based, home delivery platform for patients who have been prescribed Ketamine.
PharmaTher Files U.S. Patent for Novel Combinations of Psilocybin and FDA Approved Drugs to Treat Neurological Disorders Dec 15 • 3 min read PharmaTher Inc. announced that it has filed a provisional patent outlining the potential for novel combinations of psilocybin and U.S. Food and Drug Administration approved drugs to treat neurological disorders.
Seelos Therapeutics Raises $10 Million In Private Placement of Senior Secured Convertible Note Dec 14 • 4 min read Seelos Therapeutics, Inc. today announced the sale of a $12M senior secured convertible note and shares of Seelos common stock to investors.
MindMed Closes Upsized Financing of CAD $34.5m, Gross Proceeds Raised Since Company Founding Now Total CAD $121.4m (USD $94.8m) Dec 11 • 4 min read Mind Medicine (MindMed) Inc. announced that it has closed its previously announced bought deal short form prospectus offering.